pantoprazole has been researched along with Anemia, Cooley's in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eghbali, A | 1 |
| Khalilpour, A | 1 |
| Taherahmadi, H | 1 |
| Bagheri, B | 1 |
1 trial available for pantoprazole and Anemia, Cooley's
| Article | Year |
|---|---|
Pantoprazole reduces serum ferritin in patients with thalassemia major and intermedia: A randomized, controlled study.
Topics: Adolescent; Adult; beta-Thalassemia; Child; Deferasirox; Deferiprone; Deferoxamine; Female; Ferritin | 2019 |